On Thursday, Jim Cramer, the host of Mad Money, discussed the recent turbulence in the stock market, pointing to the lack of ...

A federal court in Texas has rejected a request by producers of compounded drugs to extend their ability to manufacture ...

Eli Lilly (LLY) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.

Whatever you think of Donald Trump’s tariff policies, one fact stands out: companies are looking to invest more in the United ...

After scoring a long-awaited FDA approval last fall, Eli Lilly has launched a consumer-facing campaign to get the word out ...

In this article, we will take a look into Eli Lilly and Co's (NYSE:LLY) DCF analysis, a reliable and data-driven approach to ...

Teladoc (TDOC) shares are climbing on Thursday after the healthcare company announced its deal with Eli Lilly's (LLY) direct-to-consumer pharmacy partner Lilly Direct. The deal is set to ...

Eli Lilly is seeking to further cement its stance as a leader in weight loss drugs in an ad campaign calling out “unapproved” medications.

It is tailored to patients being treated with Lilly's oncology drugs – which ... the negative side effects of treatment," said the company's chief executive Dr Tryggvi Thorgeirsson.

Eli Lilly has launched a new website-based access ... approach in which a patient’s prescription goes straight to the company, and is also notable as it bundles in telehealth access to doctors ...

One of the few drug developers based in Worcester is leaving Wormtown for Waltham. Also, Novo Nordisk and Eli Lilly have ...